Five Prime Therapeutics, Inc. Deferred Revenue
Five Prime Therapeutics, Inc. had Deferred Revenue of $3.35 million as of 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-08-08
- 2018-06-30: Deferred Revenue, Current $3.35M.
- 2018-03-31: Deferred Revenue, Current $4.44M.
- 2017-12-31: Deferred Revenue, Current $12.71M.
- 2017-09-30: Deferred Revenue, Current $12.57M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-06-30 | $3.35M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $4.44M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $12.71M 10-Q · filed 2018-08-08 |
| 2017-09-30 | $12.57M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $13.32M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $14.19M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $14.15M 10-K · filed 2018-02-27 |
| 2016-09-30 | $15.01M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $15.60M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $16.21M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $17.51M 10-K · filed 2017-02-24 |
| 2015-09-30 | $12.12M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $12.60M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $12.11M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $11.94M 10-K · filed 2016-03-11 |
| 2014-09-30 | $11.68M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $11.65M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $10.98M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $7.91M 10-K · filed 2015-03-18 |
| 2013-09-30 | $9.02M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $7.50M 10-K · filed 2014-03-26 |